Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy

Neuroscience Letters

Volumn 527, Issue 1, 2012, Pages 16-21

  Tanikawa, Satoshi ^a   Mori, Fumiaki ^a   Tanji, Kunikazu ^a   Kakita, Akiyoshi ^b   Takahashi, Hitoshi ^b   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Synuclein; Autophagy; CHMP2B (charged multivesicular body protein 2B); Endosome; Lewy body

Indexed keywords

ALPHA SYNUCLEIN; CHARGED MULTIVESICULAR BODY PROTEIN 2B; ESCRT PROTEIN; UNCLASSIFIED DRUG;

ALPHA SYNUCLEINOPATHY; ARTICLE; AUTOPHAGY; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; NERVE FIBER; NEUROPATHY; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; TAUOPATHY; TDP 43 PROTEINOPATHY;

ALPHA-SYNUCLEIN; BRAIN; CADAVER; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HUMANS; INCLUSION BODIES; LEWY BODIES; NEURODEGENERATIVE DISEASES; NEUROGLIA; TISSUE DISTRIBUTION;

EID: 84866491973     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.035     Document Type: Article

References (34)

1. Alvarez-Erviti L., Rodriguez-Oroz M.C., Cooper J.M., Caballero C., Ferrer I., Obeso J.A., Schapira A.H. Chaperone-mediated autophagy markers in Parkinson disease brains. Archives of Neurology 2010, 67:1464-1472.
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histology and Histopathology 1997, 12:25-31.
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 2006, 351:602-611.
4. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
5. Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., Hollinger H.C., Hartley J.A., Brockington A., Burness C.E., Morrison K.E., Wharton S.B., Grierson A.J., Ince P.G., Kirby J., Shaw P.J. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010, 5:e9872.
6. Crews L., Spencer B., Desplats P., Patrick C., Paulino A., Rockenstein E., Hansen L., Adame A., Galasko D., Masliah E. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of α-synucleinopathy. PLoS One 2010, 5:e9313.
7. Dehay B., Bove J., Rodriguez-Muela N., Perier C., Recasens A., Boya P., Vila M. Pathogenic lysosomal depletion in Parkinson's disease. Journal of Neuroscience 2010, 30:12535-12544.
8. Fader C.M., Colombo M.I. Autophagy and multivesicular bodies: two closely related partners. Cell Death and Differentiation 2009, 16:70-78.
9. Funk K.E., Mrak R.E., Kuret J. Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. Neuropathology and Applied Neurobiology 2011, 37:295-306.
10. Ghazi-Noori S., Froud K.E., Mizielinska S., Powell C., Smidak M., Fernandez de Marco M., O'Malley C., Farmer M., Parkinson N., Fisher E.M.C., Asante E.A., Brandner S., Collinge J., Isaacs A.M. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 2012, 135:819-832.
11. Hasegawa T., Konno M., Baba T., Sugeno N., Kikuchi A., Kobayashi M., Miura E., Tanaka N., Tamai K., Furukawa K., Arai H., Mori F., Wakabayashi K., Aoki M., Itoyama Y., Takeda A. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. PLoS One 2011, 6:e29460.
12. Higashi S., Moore D.J., Minegishi M., Kasanuki K., Fujishiro H., Kabuta T., Togo T., Katsuse O., Uchikado H., Furukawa Y., Hino H., Kosaka K., Sato K., Arai H., Wada K., Iseki E. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology 2011, 70:264-280.
13. Holm I.E., Englund E., Mackenzie I.R., Johannsen P., Isaacs A.M. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. Journal of Neuropathology and Experimental Neurology 2007, 66:884-891.
14. Mackenzie I.R., Neumann M., Baborie A., Sampathu D.M., Du Plessis D., Jaros E., Perry R.H., Trojanowski J.Q., Mann D.M., Lee V.M. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica 2011, 122:111-113.
15. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
16. Mori F., Nishie M., Kakita A., Yoshimoto M., Takahashi H., Wakabayashi K. Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. Journal of Neuropathology and Experimental Neurology 2006, 65:808-815.
17. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
18. Nishie M., Mori F., Fujiwara H H., Hasegawa M., Yoshimoto M., Iwatsubo T., Takahashi H., Wakabayashi K. Accumulation of phosphorylated α-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathologica 2004, 107:292-298.
19. Obita T., Saksena S., Ghazi-Tabatabai S., Gill D.J., Perisic O., Emr S.D., Williams R.L. Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vsp4. Nature 2007, 449:835-839.
20. Odagiri S., Tanji K., Mori F., Kakita A., Takahashi H., Wakabayashi K. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathologica 2012, 124:173-186.
21. Okamoto K., Hirai S., Iizuka T., Yanagisawa T., Watanabe M. Reexamination of granulovacuolar degeneration. Acta Neuropathologica 1991, 82:340-345.
22. Parkinson N., Ince P.G., Smith M.O., Highley R., Skibinski G., Andersen P.M., Morrison K.E., Pall H.S., Hardiman O., Collinge J., Shaw P.J., Fisher E.M.C. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006, 67:1074-1077. MRC Proteomics in ALS Study, FReJA Consortium.
23. Rusten T.E., Stenmark H. How do ESCRT proteins control autophagy?. Journal of Cell Science 2009, 122:2179-2183.
24. Schwarz L., Goldbaum O., Bergmann M., Probst-Cousin S., Richter-Landsberg C. Involvement of macroautophagy in multiple system atrophy and protein aggregate formation in oligodendrocytes. Journal of Molecular Neuroscience 2012, 47:256-266.
25. Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., Brandner S., Brun A., Rossor M.N., Gade A., Johannsen P., Sørensen S.A., Gydesen S., Fisher E.M., Collinge J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nature Genetics 2005, 8:806-808.
26. Stuchell-Brereton M.D., Skalicky J.J., Kieffer C., Karren M.A., Ghaffarian S., Sundquist W.I. ESCRT-III recognition by VPS4 ATPases. Nature 2007, 449:740-744.
27. Tanji K., Mori F., Kakita A., Takahashi H., Wakabayashi K. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiology of Disease 2011, 43:690-697.
28. Tanji K., Zhang H.X., Mori F., Kakita A., Takahashi H., Wakabayashi K. p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. Journal of Neuroscience Research 2012, 90:2034-2042.
29. Urwin H., Ghazi-Noori S., Collinge J., Isaacs A. The role of CHMP2B in frontotemporal dementia. Biochemical Society Transactions 2009, 37:208-212.
30. Wakabayashi K., Takahashi H., Obata K., Ikuta F. Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease. Neuroscience Letters 1992, 138:237-240.
31. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M., Takahashi H. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathologica 1998, 96:445-452.
32. Wakabayashi K., Hayashi S., Yoshimoto M., Kudo H., Takahashi H. NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathologica 2000, 99:14-20.
33. Yamazaki Y., Takahashi T., Hiji M., Kurashige T., Izumi Y., Yamawaki T., Matsumoto M. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus. Neuroscience Letters 2010, 477:86-90.
34. Zabrocki P., Bastiaens I., Delay C., Bammens T., Ghillebert R., Pellens K., De Virgilio C., Van Leuven F., Winderickx J. Phosphorylation, lipid raft interaction and traffic of α-synuclein in a yeast model for Parkinson. Biochimica et Biophysica Acta 2008, 1783:1767-1780.